Anti-SARS-CoV-2 Spike S1 (RBD) Neutralizing Antibody (V3S-0623-XY123) (CAT#: V3S-0623-XY123)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody IS-9A is a human mAb specific for SARS-CoV-2 Spike S1 protein. It exhibited more diversified binding modes, and their footprints cover the lower part (residues 373-378), the middle part (residue 408), and the upper part (residues 502-504) of the internal RBD surface. It binds to a more easily accessible area and exhibits a much higher potency but loses activity against Omicron BA.1, BA.2, and BA.4/5 variants.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Cross Reactivity The antibody lacks activity against Omicron BA.1, BA.2, and BA.4/5 variants.
Epitope The epitope covers AA 373-378, residue 408, and AA 502-504.
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut
Application Notes The binding of monoclonal antibody to SARS-CoV-2 RBDs, spike, and NTD was evaluated with ELISA. The 96-well microplate was coated with SARS-CoV-2 proteins in PBS overnight at 4°C. After washing, the plate was blocked with 3% (w/v) BSA for 2 h at room temperature. Afterw ashing, the plate was incubated with monoclonal antibody preparation for 2 h at 37°C. After washing, the plate was incubated with secondary antibody Rabbit anti-human IgG conjugated to horseradish peroxidase for 1 h at 37°C. After washing, the plate was developed by TMB substrate and the reaction was stopped by 1 M sulfuric acid. The absorbance was measured at 450 nm with an ELISA microplate reader.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry